In the era of personalized cancer treatment, large-scale genetic analysis of tumors is considered to be key for a better selection of patients for an appropriate anticancer therapy. Owing to this ...

Q2 Results, Operational Update: Record U.S. Product Sales. NGS Update Should Help Drive Adoption, Procedure Revenue …. SANUWAVE (OTC:SNWV) reported financial results for their second quarter ending ...

All the patients analyzed in this study have been seen in the context of a genetic session and fulfilled at least one the following criteria: (i) breast cancer before the age of 36, (ii) medullary ...

The Association for Molecular Pathology (AMP), the premier global, non-profit organization serving molecular diagnostic professionals, today released cost analysis results and health economic ...

AUSTIN, Texas--(BUSINESS WIRE)--Asuragen, Inc., a molecular diagnostics company delivering easy-to-use products for complex testing in genetics and oncology, today announced publication of a study ...

Dublin, Dec. 02, 2021 (GLOBE NEWSWIRE) -- The "Next-generation Sequencing Services Market by Type, Technology, Application, & End User - Forecast to 2028" report has been added to ...

Dublin, March 01, 2024 (GLOBE NEWSWIRE) -- The "Next Generation Sequencing Services Market by Type (Targeted, RNA, De Novo, WES, WGS), Technology (Sequencing by Synthesis, Ion Semiconductor, SMRT, ...

Lugano, Switzerland, 25 August 2020 - Recommendations on the use of next-generation sequencing (NGS) for patients with metastatic cancers are being launched today [25 August] by the European Society ...

Dublin, Dec. 02, 2021 (GLOBE NEWSWIRE) -- The "Next-generation Sequencing Services Market by Type, Technology, Application, & End User - Forecast to 2028" report has been added to ...